Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.

Steroids - 1 Mar 2009

Schulze Jenny Jakobsson, Lundmark Jonas, Garle Mats, Ekström Lena, Sottas Pierre-Edouard, Rane Anders

Abstract excerpt

Testosterone abuse is conventionally assessed by the urinary testosterone/epitestosterone (T/E) ratio, levels above 4.0 being considered suspicious. A deletion polymorphism in the gene coding for UGT2B17 is strongly associated with reduced testosterone glucuronide (TG) levels in urine. Many of the individuals devoid of the gene would not reach a T/E ratio of 4.0 after testosterone intake. Future test programs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Bayes Theorem
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucuronosyltransferase

Share to Minor Histocompatibility Antigens

Share to Polymorphism, Genetic

Share to Testosterone

Share to Young Adult

Source

Identifiers

PMID: 19056415
DOI: 10.1016/j.steroids.2008.11.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.PMID 19056415Read ↗

Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.Semantic proximity Read ↗

Androgens and doping tests: genetic variation and pit-falls.Semantic proximity Read ↗

Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.Semantic proximity Read ↗

UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse.Semantic proximity Read ↗

Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability.Semantic proximity Read ↗

Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians.Semantic proximity Read ↗

Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men.Semantic proximity Read ↗

[Testosterone metabolism and doping test results].Semantic proximity Read ↗

Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.Semantic proximity Read ↗

Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.Semantic proximity Read ↗

Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes.Semantic proximity Read ↗

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.